ClinicalTrials.gov
ClinicalTrials.gov Menu

Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected Patients (TERCETO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01013987
Recruitment Status : Unknown
Verified November 2009 by The Huesped Foundation.
Recruitment status was:  Recruiting
First Posted : November 16, 2009
Last Update Posted : February 10, 2010
Sponsor:
Collaborator:
Pfizer
Information provided by:
The Huesped Foundation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Study Completion Date : No date given